Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 18 for PALONOSETRON OR FOSNETUPITANT OR NETUPITANT
  1. The combination of netupitant and palonosetron is used to prevent nausea and vomiting caused by cancer chemotherapy. Netupitant is in a class of medications called neurokinin (NK1) ...
  2. Palonosetron injection is used to prevent nausea and vomiting that may occur within 24 hours after receiving ... occur several days after receiving certain chemotherapy medications. Palonosetron injection is in a class of medications called ...
  3. A to Z List of Cancer Drugs From the National Institutes of Health (National Cancer Institute)  
    National Cancer Institute ... From the National Institutes of Health ... List of cancer drug information summaries providing details about cancer drugs and cancer ...
  4. National Cancer Institute ... From the National Institutes of Health ... Nausea and vomiting related to cancer treatment (or to the cancer itself) can be a serious ...
  5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury From the National Institutes of Health (National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases)  
    National Library of Medicine ... National Institute of Diabetes and Digestive and Kidney Diseases ... LiverTox® provides up-to-date, unbiased and easily accessed ...
  6. LactMed: Drugs and Lactation Database From the National Institutes of Health (National Library of Medicine)  
    National Library of Medicine ... From the National Institutes of Health ... The LactMed® database contains information on drugs and other chemicals to which breastfeeding ...
  7. Understanding Your Pathology Report (Living Beyond Breast Cancer)  
    Living Beyond Breast Cancer ... A pathology report is a profile of the breast cancer’s characteristics, including stage, how quickly it may grow, hormone-receptor ...
  8. Triple-Negative Breast Cancer (Living Beyond Breast Cancer)  
    Living Beyond Breast Cancer ... About 10% to 15% of breast cancers are triple-negative. Learn more about the symptoms, treatment options, and myths about TNBC.
  9. Insomnia and Fatigue (Living Beyond Breast Cancer)  
    Living Beyond Breast Cancer ... Cancer-related insomnia and fatigue are very common with a breast cancer diagnosis and treatment, and can develop for many ...
  10. ... to ondansetron, alosetron (Lotronex), dolasetron (Anzemet), granisetron (Kytril), palonosetron (Aloxi, in Akynzeo), any other medications, or any ...
previous · 1 · 2 · next